Carbon Health COVID Revenue Dependence
Carbon Health
The key point is that Carbon’s 2021 peak was not proof that its clinic model had reached steady state, it was a temporary public health windfall layered on top of a much smaller core business. At roughly $230M of revenue, about 60% implies around $138M came from Covid testing and shots, which means the post pandemic reset was less a normal slowdown and more the removal of the majority of its highest demand service line.
-
Covid demand let Carbon monetize a simple high volume workflow. Patients booked a test or vaccine, showed up once, and Carbon collected visit reimbursement or program revenue without needing a long primary care relationship. That is very different from urgent care and primary care, where revenue depends on repeat visits, payer contracts, staffing, and clinic utilization.
-
The math shows how sharp the transition was. Revenue fell from about $230M in 2021 to $180M in 2022, then to roughly $77.5M in the first half of 2023. Carbon then had to rebuild around insured visits, virtual care, employer deals, and longer running care programs instead of one time pandemic services.
-
This also explains why Carbon competes differently now. Traditional urgent care chains like CityMD and GoHealth are built around steady local visit demand and mature payer contracts, while Carbon is trying to use its app, in house software, and virtual layer to make each clinic more productive and to keep patients engaged between visits.
Going forward, Carbon’s path depends on turning episodic Covid volume into repeatable non Covid care loops. The business is heading toward a model where the winning clinics are not the ones that process the most one off tests, but the ones that keep patients inside the system for urgent care, primary care, remote follow up, and employer sponsored care over time.